SCHEMBL5423746

SCHEMBL5423746

Cc1cccc(C)c1C1CCN(Cc2c(-c3ccccc3)[nH]c3ccc(Cl)cc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.57
OPRK1 P41145 3/20 0.57
HTR2A P28223 5/20 0.54
TLR9 Q9NR96 3/20 0.47
OPRL1 P41146 2/20 0.47
OPRD1 P41143 1/20 0.47
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
DRD2 P14416 4/20 0.45
KCNH2 Q12809 3/20 0.45
HTR2C P28335 2/20 0.45
PDE10A Q9Y233 1/20 0.45
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
TUBA1B P68363 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5424650 0.89 HTR2A (0.55) OPRM1OPRK1HTR2ATLR9KDM4E
SCHEMBL5434438 0.88 HTR2A (0.62) OPRM1OPRK1HTR2ATLR9POLB
SCHEMBL5421052 0.88 HTR2A (0.52) OPRM1OPRK1HTR2ATLR9OPRL1
Hydrochloric Acid SCHEMBL5417603 0.87 HTR2A (0.51) OPRM1OPRK1HTR2ATLR9OPRL1
SCHEMBL5425307 0.86 HTR1A (0.51) HTR2ATLR9POLBKDM4EHSD17B10
SCHEMBL5434473 0.82 HTR2A (0.47) OPRM1OPRK1HTR2ATLR9POLB
SCHEMBL947686 0.81 POLB (0.64) HTR2APOLBKDM4EGAAMAPT
SCHEMBL5420550 0.81 HTR2A (0.52) OPRM1OPRK1HTR2AKDM4EMAPT
SCHEMBL5430112 0.80 HTR2A (0.54) OPRM1OPRK1HTR2ATLR9OPRL1
SCHEMBL4522438 0.80 HTR2A (0.65) OPRM1OPRK1HTR2ATLR9DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor GLAXOSMITHKLINE S.P.A. (IT) 2007-08-23 US claimed
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor GLAXOSMITHKLINE S.P.A. (IT) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197603-A1 Substituted indole ligands for the orl-1 receptor OGFRL1, OPRL1, ORMDL3 OPRM1 10/4885OPRK1 5/4885HTR2A 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.